Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-26 @ 2:55 AM
Study NCT ID:
NCT03417102
Status:
COMPLETED
Last Update Posted:
2022-03-28
First Post:
2018-01-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-25
First Submit QC Date:
None
Study First Post Date:
2018-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-22
Results First Submit QC Date:
None
Results First Post Date:
2021-12-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-15
Last Update Post Date:
2022-03-28
Last Update Post Date Type:
ACTUAL